ATXG vs VRTX · $3.7M cap vs P/E 30, rev $3.33B
Addentax Group Corp (ATXG) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Addentax Group Corp (ATXG) is a integrated freight & logistics company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
Latest reported ATXG revenue for 2026-03-31 was $0. Net income was -$4.5M. Revenue was down 100.0% from 2025-03-31 to 2026-03-31. ATXG currently screens at market cap $3.7M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ATXG currently screens at market cap $3.7M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ATXG and VRTX stock pages for the full models.
Not investment advice.